Clinical Trial Update: Clinical Study of an Dendritic and Glioma Cells Fusion Vaccine With IL-12 for Treatment-naïve GBM Patients. [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial evaluating a dendritic cell and glioma cell fusion vaccine with IL-12 for treatment-naïve glioblastoma/glioma patients; current statu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• Glioma

Drugs mentioned

• dendritic and glioma cells fusion vaccine with IL-12

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Glioblastoma, Glioma | Phase 1, Phase 2 | Status: UNKNOWN